✦ LIBER ✦

322: A randomized, placebo controlled trial of aprotinin to reduce primary graft dysfunction following lung transplantation

✍ Scribed by C.S. Herrington; M.E. Prekker; M.I. Hertz; D.M. Radosevich; R.F. Kelly; V.V. Sullivan; L.L. Studenski; H.B. Bittner; S.J. Shumway; P.S. Dahlberg

Book ID: 116519842
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 134 KB
Volume: 26
Category: Article
ISSN: 1557-3117
DOI: 10.1016/j.healun.2006.11.342

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, placebo-controlled trial o

A randomized, placebo-controlled trial of aprotinin to reduce primary graft dysfunction following lung transplantation

✍ Cynthia S. Herrington; Matthew E. Prekker; Amanda K. Arrington; Daniel Susanto; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

405: A Multicenter Prospective, Randomiz

405: A Multicenter Prospective, Randomized, Placebo-Controlled Trial of a CXCL8 Inhibitor (Reparixin) To Prevent Primary Graft Dysfunction after Lung Transplantation

✍ B.F. Meyers; S. Keshavjee; M.R. Zamora; R.D. Davis; M.A. Smith; P.M. McFadden; M 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Long-term follow up of a double-blind, r

Long-term follow up of a double-blind, randomized, placebo-controlled trial of Cyclosporine Inhalation Solution (CyIS) in lung transplant recipients

✍ A.T. Iacono; W.B. Capra; S.B. Shrewsbury; B.A. Johnson; W.F. Grgurich; T.E. Corc 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Low-dose postoperative aprotinin reduces

Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: A prospective, randomized, double-blind, placebo-controlled trial

✍ John M. Alvarez; Lee R. Jackson; Clare Chatwin; Joseph J. Smolich 📂 Article 📅 2001 🏛 CTSNet 🌐 English ⚖ 110 KB

Thymoglobulin Prevents Chronic Graft-ver

Thymoglobulin Prevents Chronic Graft-versus-Host Disease, Chronic Lung Dysfunction, and Late Transplant-Related Mortality: Long-Term Follow-Up of a Randomized Trial in Patients Undergoing Unrelated Donor Transplantation

✍ Andrea Bacigalupo; Teresa Lamparelli; Giovanni Barisione; Paolo Bruzzi; Stefano 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Long-Term follow-up of a Phase I/II Rand

Long-Term follow-up of a Phase I/II Randomized, Placebo-Controlled Trial of Palifermin to Prevent Graft-versus-Host Disease (GVHD) after Related Donor Allogeneic Hematopoietic Cell Transplantation (HCT)

✍ John E. Levine; Bruce R. Blazar; Todd DeFor; James L.M. Ferrara; Daniel J. Weisd 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 160 KB